These immunocytokines combine the specificity of an anti-CD138 IgG1 mAb with the anti-MM activity of an IFNα14, IFNα2, or IFNα2YNS (high-affinity IFNα2 mutant) moiety (161, 163). This evidence concerns the gene SDC1 and Miyoshi myopathy.